Researchers have developed an artificial intelligence platform to detect a range of neurodegenerative disease in human brain tissue samples, including Alzheimer’s disease and chronic traumatic encephalopathy, according to a study conducted at the Icahn School of Medicine at Mount Sinai and…
Tackling Parkinson’s With Targeted Drug Discovery
The failures and lack of progress in the development of new treatments for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, are well documented. But, finally, for patients who are desperately awaiting treatment, things may be changing. Advances in our understanding…
Analyzing Metagenome Helps Understand the Role of Bacterial Species in Crohn’s Disease
Research Overview on the Gut Metagenome Research on gut metagenome of patients with Crohn’s disease elucidates how it influences the taxonomic and functional composition of intestinal microbiota. Among the most common changes are the decrease in the diversity of beneficial microbes…
Sporadic Alzheimer’s in a Dish
The new cell model of the most common form of Alzheimer’s points to molecular causes, drug target Harvard Medical School geneticists has created a new model-in-a-dish of sporadic Alzheimer’s disease, which accounts for more than 90 percent of Alzheimer’s cases and…
Study Links Protein, Clusterin, to Cardiac and Metabolic Diseases
During a study spanning nearly a decade, researchers at The Ohio State University College of Medicine, Houston Methodist Research Institute, and Houston Methodist Cancer Center have linked the protein clusterin—for the first time—too many different facets of cardiometabolic syndrome risk through…
NIH-Supported Scientists Develop Tool to Measure Success of HIV Cure Strategies
Scientists funded by the National Institutes of Health have developed a new assay to accurately and easily count the cells that comprise the HIV reservoir, the stubborn obstacle to an HIV cure. This advance will enable researchers who are trying to…
New Leukemia Drug is More Effective and Easier to Use
A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging normal…
Novel Protein Could Enhance Treatment For Breast Cancer
Research led by Suresh Alahari, Ph.D., the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health New Orleans School of Medicine, has found a new role for a protein discovered by his lab in preventing the growth and spread…
Rising Drug Prices Linked to Older Products, Not Just Newer, Better Medications
It’s no secret that drug prices are increasing, but to what extent are rising costs explained by the advent of newer, better drugs? A study from the University of Pittsburgh found that new drugs entering the market do drive up prices,…